Skip to main content
. 2019 Aug 18;9(8):e029966. doi: 10.1136/bmjopen-2019-029966

Table 3.

Association with intervention intensity with weight loss achieved and mortality

Characteristic Weight loss
(from baseline and final reported)*
Mortality
N studies† Weight of studies Mean difference
Random effect model
(kg) (95% CI)
N studies Weight of studies Total deaths/total patients
(mortality rate)
OR
Fixed effect model (95% CI)
Number of interventions per year
≤6 3 9% 0.84 (0.28 to 1.40) 3 1% 5/510 (1.0%) 1.45 (0.22 to 9.40)
7–12 6 17% 2.04 (0.84 to 3.24) 6 2% 10/2022 (0.5%) 1.34 (0.35 to 5.16)
13–24 4 15% 2.46 (0.67 to 5.59) 6 4% 23/3490 (0.7%) 1.20 (0.49 to 2.96)
≥25 17 60% 3.53 (2.92 to 4.13) 17 93% 555/13578 (4.1%) 0.84 (0.71 to 1.00)
 BMI‡
25–29 6 19% 1.37 (−0.09 to 2.82) 8 11% 23/3890 (0.6%) 1.58 (0.64 to 3.90)
30–35 16 48% 3.09 (2.11 to 4.06) 14 22% 136/8374 (1.6%) 0.93 (0.65 to 1.33)
>35 6 23% 4.04 (2.47 to 5.61) 6 67% 384/6370 (6%) 0.86 (0.69 to 1.05)
Comorbidities
Cardiometabolic risk factor present 16 56% 2.86 (2.10 to 3.63) 18 90% 529/14311 (3.7%) 0.90 (0.75 to 1.08)
Healthy population 8 29% 3.03 (1.53 to 4.52) 8 3% 12/3458 (0.3%) 1.23 (0.39 to 3.89)
Other (arthritis, asthma and mental illness) 4 9% 3.35 (2.18 to 4.52) 4 2% 7/1275 (0.6%) 0.74 (0.16 to 3.37)
Cancer 2 6% 2.70 (1.57 to 3.83) 2 6% 2/438 (0.5%) 0.98 (0.06 to 15.74)
Age (years)
40–49 12 47% 2.29 (0.97 to 3.61) 14 9% 50/9868 (0.5%) 1.28 (0.71 to 2.30)
50–59 12 39% 3.27 (2.38 to 4.15) 12 69% 396/9691 (3.8%) 0.84 (0.69 to 1.04)
>60 7 14% 4.50 (2.76 to 6.25) 7 22% 155/2202 (7.0%) 0.78 (0.55 to 1.10)
Look AHEAD 1 4% 3.40 (3.30 to 3.50) 1 65% 376/5145 (7.3%) 0.85 (0.69 to 1.05)
All other studies 29 96% 3.01 (2.23 to 3.79) 32 35% 207/14455 (1.4%) 0.88 (0.66 to 1.17)
Total 30 100% 2.95 ( 2.35 to 3.55) 32 100% 593/19463 (3.1%) 0.86 ( 0.73 to 1.02)

*P<0.0001 for all.

†Da Quing excluded for all weight loss.

‡TAIM55 and HCP22 excluded for BMI.

BMI, body mass index.